Back to dashboard
PhoenixPharma SAS
CUST-068CustomerTier 1Low🇬🇧Headquarters: United KingdomIndustry: VenturesFounded: 1988Annual volume (USD): $465.5M
8
/ 100
Overall composite score
LowSix-dimension risk breakdown
Contributing factors
Direct Sanctions Hit
No matching entries
0
Weight 60%
Why this score: HQ jurisdiction United Kingdom drives this factor: comprehensive sanctions => 100; partial => 75; no sanctions => 0.
UBO Sanctions Exposure
0 of 2 UBO(s) reside in sanctioned jurisdictions
0
Weight 30%
Why this score: Each UBO residing in a comprehensively sanctioned / FATF blacklist country contributes 60 to the score, capped at 100.
Fuzzy Watchlist Match
3% similarity to an entry on aggregated sanctions lists
3
Weight 10%
Why this score: Fuzzy name similarity against OFAC/UN/EU/OpenSanctions. Lower alone is not conclusive; this serves as an investigative trigger.
Operating jurisdictions
- 🇬🇧United Kingdom
- 🇮🇹Italy
- 🇲🇾Malaysia
- 🇦🇹Austria
- 🇦🇺Australia
Subsidiaries
- 🇸🇪Evergreen Connectors (SE)
- 🇧🇷Pinnacle Connectors (BR)
Ultimate beneficial owners
- 🇪🇸Yusuf Ivanov
- 🇺🇸Mei Ivanov